(Q73035541)
Statements
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand (English)
Bielekova B
Goodwin B
Richert N
Cortese I
Kondo T
Afshar G
Eaton J
Antel J
Frank JA